Skip to menu Skip to content Skip to footer
Dr Luis Furuya Kanamori
Dr

Luis Furuya Kanamori

Email: 

Overview

Background

Dr Luis Furuya Kanamori MBBS, MEpi, MPH, PhD, FACTM is a clinical epidemiologist and research synthesis methodologist. He is an international leader in travel medicine, vaccine preventable diseases, and research synthesis, and has been listed in Stanford University’s World top 2% of scientists.

Dr Furuya Kanamori leads the Travel Medicine and Vaccine Preventable Diseases Theme, and the Clinician-Epidemiologist Hub at UQ's HERA program on Operational Research and Decision Support for Infectious Diseases (ODeSI). He is Director of Research of the Clinical Research & Evidence Synthesis (CRESTMA) at the Travel Medicine Alliance (TMA), network of 30+ travel medicine clinics in Australia.

Dr Furuya Kanamori’s applied research on travel medicine and vaccine preventable diseases has influenced key changes in clinical and public health guidelines (e.g., WHO, ATAGI, Australian Immunisation Handbook, UptoDate). His methodological work on publication bias (LFK index) has been implemented in MetaXL, Stata, and R, and has been utilised in 800+ published meta-analyses.

In addition to his academic roles, Dr Furuya Kanamori is editorial board member for J Travel Med and Clin Infect Dis, and chairs the Research and Awards Committee of the International Society of Travel Medicine.

Availability

Dr Luis Furuya Kanamori is:
Available for supervision

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, Universidad Peruana Cayetano Heredia
  • Masters (Coursework) of Epidemiology, The University of Queensland
  • Masters (Coursework) of Public Health, The University of Queensland
  • Doctor of Philosophy, Australian National University

Research interests

  • Travel Medicine

    Vaccine fractional dosing | Malaria chemoprophylaxis | STIs | Causes of death | Decision support systems | Personalised risk assessment | Clinical trials

  • Vaccine preventable diseases

    Rabies PrEP and PEP | Japanese encephalitis | Yellow fever | Vaccine safety

  • Research synthesis and meta-analysis

    Publication bias | Diagnostic accuracy studies | Quality information | Rare/zero-events studies | Rapid meta-analysis

Works

Search Professor Luis Furuya Kanamori’s works on UQ eSpace

157 works between 2013 and 2024

41 - 60 of 157 works

2022

Journal Article

Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies

Peri, Anna Maria, Ling, Weiping, Furuya-Kanamori, Luis, Harris, Patrick N. A. and Paterson, David L. (2022). Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies. BMC Infectious Diseases, 22 (1) 794, 1-14. doi: 10.1186/s12879-022-07772-x

Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies

2022

Journal Article

Japanese encephalitis emergence in Australia: the potential population at risk

Yakob, Laith, Hu, Wenbiao, Frentiu, Francesca D, Gyawali, Narayan, Hugo, Leon E, Johnson, Brian, Lau, Colleen, Furuya-Kanamori, Luis, Magalhaes, Ricardo Soares and Devine, Gregor (2022). Japanese encephalitis emergence in Australia: the potential population at risk. Clinical Infectious Diseases, 76 (2), 335-337. doi: 10.1093/cid/ciac794

Japanese encephalitis emergence in Australia: the potential population at risk

2022

Journal Article

Limits in the search date for rapid reviews of diagnostic test accuracy studies

Furuya‐Kanamori, Luis, Lin, Lifeng, Kostoulas, Polychronis, Clark, Justin and Xu, Chang (2022). Limits in the search date for rapid reviews of diagnostic test accuracy studies. Research Synthesis Methods, 14 (2), 173-179. doi: 10.1002/jrsm.1598

Limits in the search date for rapid reviews of diagnostic test accuracy studies

2022

Journal Article

Diagnostic accuracy of multiplex nucleic acid amplification tests for Campylobacter infection: a systematic review and meta-analysis

Rousou, Xanthoula, Furuya-Kanamori, Luis, Kostoulas, Polychronis and Doi, Suhail A.R. (2022). Diagnostic accuracy of multiplex nucleic acid amplification tests for Campylobacter infection: a systematic review and meta-analysis. Pathogens and Global Health, 117 (3), 259-272. doi: 10.1080/20477724.2022.2097830

Diagnostic accuracy of multiplex nucleic acid amplification tests for Campylobacter infection: a systematic review and meta-analysis

2022

Journal Article

Synthesizing evidence from the earliest studies to support decision‐making: to what extent could the evidence be reliable?

Yu, Tianqi, Lin, Lifeng, Furuya‐Kanamori, Luis and Xu, Chang (2022). Synthesizing evidence from the earliest studies to support decision‐making: to what extent could the evidence be reliable?. Research Synthesis Methods, 13 (5), 632-644. doi: 10.1002/jrsm.1587

Synthesizing evidence from the earliest studies to support decision‐making: to what extent could the evidence be reliable?

2022

Journal Article

Carriage duration and household transmission of Enterobacterales producing extended-spectrum beta-lactamase in the community: a systematic review and meta-analysis

Ling, Weiping, Peri, Anna Maria, Furuya-Kanamori, Luis, Harris, Patrick N.A. and Paterson, David L. (2022). Carriage duration and household transmission of Enterobacterales producing extended-spectrum beta-lactamase in the community: a systematic review and meta-analysis. Microbial Drug Resistance, 28 (7), 1-11. doi: 10.1089/mdr.2022.0035

Carriage duration and household transmission of Enterobacterales producing extended-spectrum beta-lactamase in the community: a systematic review and meta-analysis

2022

Journal Article

Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis

Islam, Nazmul, Xu, Chang, Lau, Colleen L., Mills, Deborah J., Clark, Justin, Devine, Gregor J., Hugo, Leon E., Gyawali, Narayan, Thalib, Lukman and Furuya-Kanamori, Luis (2022). Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis. Vaccine, 40 (26), 3546-3555. doi: 10.1016/j.vaccine.2022.04.079

Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis

2022

Journal Article

Perspectives of persons with type 2 diabetes toward diabetes self-management: a qualitative study

Othman, Manal M., Al-Wattary, Noor A., Khudadad, Hanan, Dughmosh, Ragae, Furuya-Kanamori, Luis, Doi, Suhail A. R. and Daher-Nashif, Suhad (2022). Perspectives of persons with type 2 diabetes toward diabetes self-management: a qualitative study. Health Education and Behavior, 49 (4), 680-688. doi: 10.1177/10901981221098373

Perspectives of persons with type 2 diabetes toward diabetes self-management: a qualitative study

2022

Journal Article

The emergence of Japanese encephalitis in Australia and the implications for a vaccination strategy

Furuya-Kanamori, Luis, Gyawali, Narayan, Mills, Deborah J., Hugo, Leon E., Devine, Gregor J. and Lau, Colleen L. (2022). The emergence of Japanese encephalitis in Australia and the implications for a vaccination strategy. Tropical Medicine and Infectious Disease, 7 (6) 85, 85. doi: 10.3390/tropicalmed7060085

The emergence of Japanese encephalitis in Australia and the implications for a vaccination strategy

2022

Journal Article

Validity of data extraction in evidence synthesis practice of adverse events: reproducibility study

Xu, Chang, Yu, Tianqi, Furuya-Kanamori, Luis, Lin, Lifeng, Zorzela, Liliane, Zhou, Xiaoqin, Dai, Hanming, Loke, Yoon and Vohra, Sunita (2022). Validity of data extraction in evidence synthesis practice of adverse events: reproducibility study. BMJ, 377 e069155, 1-10. doi: 10.1136/bmj-2021-069155

Validity of data extraction in evidence synthesis practice of adverse events: reproducibility study

2022

Journal Article

Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis

Mills, Deborah J., Lau, Colleen L., Mills, Christine and Furuya-Kanamori, Luis (2022). Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis. Journal of Travel Medicine, 29 (2) taab188. doi: 10.1093/jtm/taab188

Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis

2022

Journal Article

Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia

Islam, Nazmul, Lau, Colleen, Leeb, Alan, Mills, Deborah and Furuya-Kanamori, Luis (2022). Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia. Human Vaccines & Immunotherapeutics, 18 (1) 2020573, 2020573. doi: 10.1080/21645515.2021.2020573

Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia

2022

Journal Article

Has the COVID-19 pandemic lockdown worsened eating disorders symptoms among patients with eating disorders? A systematic review

Gao, Yunqi, Bagheri, Nasser and Furuya-Kanamori, Luis (2022). Has the COVID-19 pandemic lockdown worsened eating disorders symptoms among patients with eating disorders? A systematic review. Journal of Public Health, 30 (11), 1-10. doi: 10.1007/s10389-022-01704-4

Has the COVID-19 pandemic lockdown worsened eating disorders symptoms among patients with eating disorders? A systematic review

2022

Journal Article

Determinants of atrial fibrillation development among patients undergoing Ibrutinib therapy

Onitilo, Adedayo A., Piwuna, Tinuade O., Islam, Nazmul, Furuya-Kanamori, Luis, Kumar, Sanjay and Doi, Suhail A.R. (2022). Determinants of atrial fibrillation development among patients undergoing Ibrutinib therapy. Clinical Medicine and Research, 20 (1), 16-22. doi: 10.3121/cmr.2021.1693

Determinants of atrial fibrillation development among patients undergoing Ibrutinib therapy

2022

Journal Article

Overconfident results with the bivariate random effects model for meta-analysis of diagnostic accuracy studies

Furuya-Kanamori, Luis, Meletis, Eletherios, Xu, Chang, Kostoulas, Polychronis and Doi, Suhail Ar (2022). Overconfident results with the bivariate random effects model for meta-analysis of diagnostic accuracy studies. Journal of Evidence-Based Medicine, 15 (1), 6-9. doi: 10.1111/jebm.12467

Overconfident results with the bivariate random effects model for meta-analysis of diagnostic accuracy studies

2022

Journal Article

Towards a better understanding of self-management interventions in type 2 diabetes: a concept analysis

Othman, Manal M., Khudadad, Hanan, Dughmosh, Ragae, Furuya-Kanamori, Luis, Abou-Samra, Abdul-Badi and Doi, Suhail A.R. (2022). Towards a better understanding of self-management interventions in type 2 diabetes: a concept analysis. Primary Care Diabetes, 16 (1), 142-149. doi: 10.1016/j.pcd.2021.09.001

Towards a better understanding of self-management interventions in type 2 diabetes: a concept analysis

2022

Journal Article

Unifying the diagnosis of gestational diabetes mellitus: introducing the NPRP criteria

Doi, Suhail A.R., Bashir, Mohammed, Sheehan, Michael T., Onitilo, Adedayo A., Chivese, Tawanda, Ibrahim, Ibrahim M., Beer, Stephen F., Furuya-Kanamori, Luis, Abou-Samra, Abdul-Badi and McIntyre, H. David (2022). Unifying the diagnosis of gestational diabetes mellitus: introducing the NPRP criteria. Primary Care Diabetes, 16 (1), 96-101. doi: 10.1016/j.pcd.2021.08.006

Unifying the diagnosis of gestational diabetes mellitus: introducing the NPRP criteria

2022

Journal Article

Comment on a review of methods to assess publication and other reporting biases in meta‐analysis

Furuya‐Kanamori, Luis, Lin, Lifeng and Doi, Suhail A. R. (2022). Comment on a review of methods to assess publication and other reporting biases in meta‐analysis. Research Synthesis Methods, 13 (4), 390-391. doi: 10.1002/jrsm.1550

Comment on a review of methods to assess publication and other reporting biases in meta‐analysis

2022

Journal Article

The Odds Ratio is “portable” across baseline risk but not the Relative Risk: Time to do away with the log link in binomial regression

Doi, Suhail A., Furuya-Kanamori, Luis, Xu, Chang, Chivese, Tawanda, Lin, Lifeng, Musa, Omran A.H., Hindy, George, Thalib, Lukman and Harrell, Frank E. (2022). The Odds Ratio is “portable” across baseline risk but not the Relative Risk: Time to do away with the log link in binomial regression. Journal of Clinical Epidemiology, 142, 288-293. doi: 10.1016/j.jclinepi.2021.08.003

The Odds Ratio is “portable” across baseline risk but not the Relative Risk: Time to do away with the log link in binomial regression

2022

Journal Article

The prevalence of adaptive immunity to COVID-19 and reinfection after recovery–a comprehensive systematic review and meta-analysis

Chivese, Tawanda, Matizanadzo, Joshua T., Musa, Omran A. H., Hindy, George, Furuya-Kanamori, Luis, Islam, Nazmul, Al-Shebly, Rafal, Shalaby, Rana, Habibullah, Mohammad, Al-Marwani, Talal A., Hourani, Rizeq F., Nawaz, Ahmed D., Haider, Mohammad Z., Emara, Mohamed M., Cyprian, Farhan and Doi, Suhail A. R. (2022). The prevalence of adaptive immunity to COVID-19 and reinfection after recovery–a comprehensive systematic review and meta-analysis. Pathogens and Global Health, 116 (5), 1-13. doi: 10.1080/20477724.2022.2029301

The prevalence of adaptive immunity to COVID-19 and reinfection after recovery–a comprehensive systematic review and meta-analysis

Funding

Current funding

  • 2024 - 2025
    JEV IgM persistence following vaccination
    Queensland Health
    Open grant

Past funding

  • 2023 - 2024
    Development of a protocol for defining and identifying high-threat 1 pathogens to support WHO STAR HTP risk assessments in the Southeast Asia Region
    World Health Organisation South-East Asia Regional Office
    Open grant
  • 2022 - 2024
    Japanese Encephalitis Vaccine Risk-Benefit Analysis Tool (International Society of Travel Medicine grant administered by Dr Deb The Travel Doctor)
    Dr Deb The Travel Doctor Pty Ltd
    Open grant
  • 2021 - 2023
    JEVID - Japanese Encephalitis Vaccination via IntraDermal route
    The International Society of Travel Medicine Research Grant
    Open grant
  • 2021 - 2023
    Reducing the risk of importing multidrug resistant enterobacteriaceae into Australia
    NHMRC Early Career Fellowships
    Open grant

Supervision

Availability

Dr Luis Furuya Kanamori is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Vaccine preventable diseases in travellers

  • Causes of death in travellers

  • Risk benefit analysis and decision support tools for vaccines

  • Advancements in research synthesis methods and meta-analyses

Supervision history

Current supervision

  • Doctor Philosophy

    Assessing risk of importation of sexually transmitted infections into Australia by international travellers

    Principal Advisor

    Other advisors: Professor Colleen Lau, Associate Professor Judith Dean

  • Doctor Philosophy

    Machine learning in epidemiology research on African Swine Fever epidemic in the Philippines Outline

    Associate Advisor

    Other advisors: Professor Colleen Lau

Completed supervision

Media

Enquiries

For media enquiries about Dr Luis Furuya Kanamori's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au